Akebia Therapeutics, Inc. Quarterly Goodwill in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Akebia Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2018 to Q2 2024.
  • Akebia Therapeutics, Inc. Goodwill for the quarter ending June 30, 2024 was $59M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $59M $0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $59M $0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $59M $0 0% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $59M $0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $59M $0 0% Jun 30, 2023 10-Q 2023-08-28
Q1 2023 $59M $0 0% Mar 31, 2023 10-Q 2023-08-28
Q4 2022 $59M $0 0% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $59M +$3.99M +7.25% Sep 30, 2022 10-K/A 2023-08-28
Q2 2022 $59M +$3.99M +7.25% Jun 30, 2022 10-Q 2023-08-28
Q1 2022 $59M +$3.99M +7.25% Mar 31, 2022 10-Q 2023-08-28
Q4 2021 $59M +$3.99M +7.25% Dec 31, 2021 10-K/A 2023-08-28
Q3 2021 $55.1M $0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $55.1M $0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $55.1M $0 0% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $55.1M $0 0% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $55.1M $0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $55.1M $0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $55.1M $0 0% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $55.1M $0 0% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $55.1M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $55.1M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $55.1M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $55.1M Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.